Senior Director of Product Management – Assay & Consumables Portfolio at Alamar Biosciences

Fremont, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Life Sciences, DiagnosticsIndustries

Requirements

Deep understanding of the proteomics and immunoassay market
Bachelor’s degree in Life Sciences required; MBA or PhD preferred
15–20 years of product management experience, including leadership of teams
Proven track record and ability to develop business models and grow revenue
Strong technical and business acumen with experience in life sciences marketing, product management, and market research
Excellent verbal and written communication skills, including ability to present technical information to diverse audiences
Strong customer-facing experience and ability to build lasting relationships
Strong focus on culture, teamwork, and mission-driven mindset

Responsibilities

Assess market trends, customer needs, and competitors to find growth and product innovation opportunities
Direct new product introductions (NPI) from concept to launch, including research, requirements, value propositions, transition planning, and training development
Develop and execute content strategy for consumables portfolio to ensure adoption and differentiation
Build and maintain KOL networks; coordinate and lead meetings to capture input on assay content and customer requirements
Become an evangelist for Alamar and present at scientific conferences and customer sites to promote products and thought leadership
Oversee portfolio supply, demand, revenue, margin, and pricing; provide regular business reviews and forecasts to management, finance, and manufacturing based on a deep understanding of the business
Collaborate cross-functionally with R&D, Sales, Program Management, and Manufacturing to deliver business objectives
Lead and mentor a team of product managers, fostering collaboration and accountability
Drive project scope, budget, and schedule to ensure successful delivery
Resolve conflicts and manage multiple stakeholders
Travel up to 25% (domestic and international)

Skills

Product Management

Proteomics

Immunoassay

New Product Introduction

NPI

Content Strategy

Market Analysis

Customer Requirements

KOL Networks

Business Growth

Team Management

Roadmap Development

Value Propositions

Alamar Biosciences

Develops technology for protein detection and measurement

About Alamar Biosciences

Alamar Biosciences focuses on the study of proteins, known as proteomics, to enhance disease detection and treatment. The company has created NULISA™, a technology that can detect and measure proteins in the human body with high sensitivity and a wide range. This allows researchers and clinicians to profile clinically relevant protein biomarkers, which are essential for developing new diagnostic tests and treatments for various diseases. Alamar's ARGO™ system complements NULISA™ by providing a fully automated, high-throughput platform for precision proteomics. Unlike competitors, Alamar's technology simplifies the process, reducing the need for extensive technical expertise, making it more accessible to clients. The goal of Alamar Biosciences is to improve our understanding of proteins in health and disease, ultimately leading to better early detection and treatment options.

Hayward, CaliforniaHeadquarters

2018Year Founded

$225.7MTotal Funding

GRANTCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

401(k) Company Match

401(k) Retirement Plan

Performance Bonus

Company Equity

Risks

Increased competition from Olink and SomaLogic may impact Alamar's market share.

Scaling production in Europe and APAC could strain resources and affect quality.

Regulatory hurdles in new regions may delay product launches and affect revenue.

Differentiation

Alamar's NULISA™ technology offers unprecedented sensitivity in protein detection.

The ARGO™ system automates high-throughput proteomics, reducing the need for technical expertise.

Alamar's focus on early disease detection sets it apart in the biotechnology field.

Upsides

ISO 13485:2016 certification boosts Alamar's credibility in the medical device industry.

European expansion with Milan headquarters enhances market reach and client service.

$10M investment accelerates Alzheimer's diagnostics development, strengthening Alamar's market position.

Land your dream remote job 3x faster with AI

Try Jobo Free